Source link : https://www.mesothelioma-info.org/2020/02/11/brief-sellas-enrolls-first-patient-in-early-stage-trial-of-galinpepimut-s-in-combination-with-opdivo/

… NIVOLUMAB (OPDIVO®) IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) Source text for Eikon: Further company coverage:.

Source link : https://uk.reuters.com/article/brief-sellas-enrolls-first-patient-in-ea/brief-sellas-enrolls-first-patient-in-early-stage-trial-of-galinpepimut-s-in-combination-with-opdivo-idUKASA00CUL

Author :

Publish date : 2020-02-11 13:41:15

Copyright for syndicated content belongs to the linked Source.

Author : mesothelioma

Publish date : 2020-02-11 22:16:07

Copyright for syndicated content belongs to the linked Source.